PFE.NYSEPfizer INC

13F-HR: Pfizer 13F Holdings — September 30, 2026

Institutional Holdings Report (13F)


Pfizer Inc reported 20 holdings worth $164.2M for the period ended September 30, 2026.

Summary

  • Pfizer Inc reported 20 holdings worth $164.2M as of September 30, 2026.
  • ALLOGENE THERAPEUTICS INC — $36.4M (22.13%), 22,032,040 SH.
  • ARVINAS INC — $26.2M (15.98%), 3,457,815 SH.
  • CELCUITY INC — $23.5M (14.31%), 295,652 SH.
  • AGOMAB THERAPEUTICS NV — $22.6M (13.77%), 2,151,213 SH.
  • PYXIS ONCOLOGY INC — $17.0M (10.36%), 5,952,263 SH.

Top Holdings

Pfizer Inc · 20 positions · $164.2M total · as of September 30, 2026
IssuerValue% Port.Shares
ALLOGENE THERAPEUTICS INC$36.4M22.13%22,032,040
ARVINAS INC$26.2M15.98%3,457,815
CELCUITY INC$23.5M14.31%295,652
AGOMAB THERAPEUTICS NV$22.6M13.77%2,151,213
PYXIS ONCOLOGY INC$17.0M10.36%5,952,263
WAVE LIFE SCIENCES INC$7.1M4.32%1,875,000
BIOHAVEN LTD$6.6M4%505,645
CARIBOU BIOSCIENCES INC$5.8M3.54%4,690,431
ORIC PHARMACEUTICALS INC$4.9M2.99%372,904
PYXIS ONCOLOGY INC$3.1M1.88%1,080,507

Keywords

13F, institutional holdings, Pfizer Inc, ALLOGENE THERAPEUTICS INC, ARVINAS INC, CELCUITY INC, AGOMAB THERAPEUTICS NV, PYXIS ONCOLOGY INC

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.